During the past decade, National Hospital Organization Kobe Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kobe Medical Center" #1 sponsor was "Bayer" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Gynecologic Oncology Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kobe Medical Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kobe Medical Center" are "Heart Failure" (3 trials), "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Adult Type Ovarian Granulosa Cell Tumor" (1 trials) and "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "National Hospital Organization Kobe Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kobe Medical Center" are "Drug" (11 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Paclitaxel" (3 trials), "Carboplatin" (2 trials), "Darbepoetin alfa" (2 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kobe Medical Center" are 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "National Hospital Organization Kobe Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in National Hospital Organization Kobe Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kobe Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".